Investors Contact Payment Careers Research Request Physician Portal
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Support
  • Lab
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request
  • Physician Portal

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Announces Closing of $3.9 Million Public Offering

Feb 8, 2017

Interpace Diagnostics Announces Pricing of Public Offering to Raise $3.6 Million

Feb 3, 2017

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

Feb 2, 2017

Interpace Diagnostics to Present at NobleCon13

Jan 25, 2017

Interpace Diagnostics Announces $4.0 Million Registered Direct Offering of Common Stock

Jan 20, 2017

Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

Jan 17, 2017

Interpace Diagnostics Announces $4.2 Million Registered Direct Offering of Common Stock

Jan 3, 2017

Interpace Diagnostics Group Announces 1-for-10 Reverse Split

Dec 28, 2016

Interpace Diagnostics Announces $1.9 Million Registered Direct Offering of Common Stock

Dec 19, 2016

Interpace Diagnostics Announces New Aetna Coverage Policy

Dec 8, 2016
    • 1...
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    © 2025 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap Manage Cookie Preferences
    We Own Our Future Logo
    • Linkedin